Ávila AME

Language: Spanish
References: 14
Page: 31-34
PDF size: 38.48 Kb.

ABSTRACT

For more than ten years it has been almost a general practice, throughout the world to overdiagnose attention-deficit hyperactivity disorder and give stimulants treatment mostly at the suggestion of teachers or parents. The syndrome seems to have a neurobiologic explanation and since amphetamines could have ill effects, physicians should be careful in backing-up layman’s indications. The diagnostic basis are explained as well as the rules of treatment because metilphenidate does improve attention in any child, but ethical considerations should be made, due to possible later counter benefits. The way to respond to parents questions are also described.

REFERENCES

1. Barkley RA. Attention-deficit hyperactivity disorder. Sci Am 1998: 66-71.

2. Cantwell DP. Genetics of hyperactivity. J Child Psychol Psychiat 1975; 16: 261-64.

3. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiat 1998; 44: 951-58.

4. Francisco de la Peńa O. El trastorno por déficit de atención con hiperactividad. Rev Fac Med 2000; 43(6): 1-4.

5. Rodríguez CR. Vademecum académico de medicamentos. McGraw-Hill Interamericana, 3Ş edición. México. 1999: 618.

6. Rubia K, Osterlaand J, Sergeant JA et al. Inhibitory dysfunction in hyperactive boys. 1998; 94: 25-32.

7. Russell V, Villiers A, Lamm M et al. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of 3H dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 1998; 94: 163-71.

8. Saaguolden T, Sergeant JA. Attention-deficit hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 1998; 94: 1-10.

9. Sagvolden T, Aase T, Zeiner P et al. Altered reinforcement mechanisms in attention-deficit hyperactivity disorder. Behav Brain Res 1998; 94: 61-71.

10. Schmitz S, Fulker DW, Mrazek DA. Problem behaviour in early and middle childhood: An initial behaviour genetic analysis. J Child Psichol Psychiat 1995; 36: 1443-58.

11. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998; 94: 127-52.

12. Sonuga-Barke EJS, Saxton T, Hall M. The role of interval understimation in hyperactive children’s failure to supress responses over time. Behav Brain Res 1998; 94: 45-50.

13. Wolraich ML, Wilson DB, White JW. The effect of sugar on behaviour or cognition in children. JAMA 1995; 274: 1617-21.

14. Zametkin AJ, Rapoport JL. Neurobiology of attention-deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiat 1987; 26: 676-86.